Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that injects tumors with radioactive material in simple needle procedure

NoCamels: Clinical-stage small molecule drugmaker announces merger with Big Rock Partners Acquisition Corporation to trade on Nasdaq exchange

Tel Aviv-based startup uses AI to build digital models of the human immune system and diseases to speed up treatments; two firms will test out new drugs

KAHR's leading drug candidate, now in clinical trials, is based on a compound that targets cancer cells, weakens their defenses and activates a local immune response

In pivot, biotech firm that makes burn and wound treatments will start clinical trial for new drug candidate in Q2 in three US medical centers

Under the terms of license agreement, Biond could get $1 billion as milestones met; Sanofi will be in charge of commercialization and clinical development

Consortium of pharma and tech giants, including Merck, Teva, Amazon, will run new innovation lab to develop ecosystem, tap into new tech

Jerusalem's Gamida Cell says 'lifesaving' stem-cell therapy helps increase success of bone marrow transplants; firm hopes to launch treatment in US in second half of 2021

Mayor Tal Ohana hopes Israel's first vaccine manufacturing plant will be set up in her town in joint venture with international player

Israeli company Kadimastem says interim results of first patient group indicate new drug 'managed to significantly slow down disease progression'